Mirae Asset Global ETFs Holdings
DNTH icon

Mirae Asset Global ETFs Holdings’s Dianthus Therapeutics DNTH Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio DNTH Stock Details DNTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.53M Buy
25,990
+6,956
+37% +$608K ﹤0.01% 1134
2026
Q1 		$1.59M Sell
19,034
-13,005
-41% -$753K ﹤0.01% 1282
2025
Q4 		$1.32M Buy
32,039
+23,634
+281% +$916K ﹤0.01% 1367
2025
Q3 		$331K Sell
8,405
-3,686
-30% -$94.2K ﹤0.01% 2062
2025
Q2 		$224K Sell
12,091
-3,243
-21% -$60.8K ﹤0.01% 2220
2025
Q1 		$280K Buy
15,334
+618
+4% +$13.6K ﹤0.01% 2142
2024
Q4 		$320K Buy
14,716
+352
+2% +$9.05K ﹤0.01% 2136
2024
Q3 		$393K Buy
+14,364
New +$400K ﹤0.01% 2037

Other funds holding DNTH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's DNTH Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings increased its Dianthus Therapeutics (DNTH) stake by 37% in Q2 2026, buying an estimated $608K and bringing the position to 25,990 shares worth $2.53M. The position accounts for ﹤0.01% of the portfolio, ranked #1134.

Mirae Asset Global ETFs Holdings first reported a position in DNTH in Q3 2024 and has held it in 8 quarters since. 270 funds tracked by Wall St. Rank hold DNTH as of Q2 2026.

  • Mirae Asset Global ETFs Holdings held 25,990 shares of Dianthus Therapeutics worth $2.53M as of Q2 2026.
  • Mirae Asset Global ETFs Holdings bought 6,956 Dianthus Therapeutics shares in Q2 2026, an estimated $608K.
  • Dianthus Therapeutics made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #1134 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Dianthus Therapeutics in Q3 2024 and has held it in 8 quarters since.
  • 270 funds tracked by Wall St. Rank held Dianthus Therapeutics as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.